Background: The hippocampus, entorhinal cortex, and fusiform gyrus are brain areas that
deteriorate during early-stage Alzheimer's disease (AD). The ApoE4 allele has been …

We evaluated how the impact of apolipoprotein E4 (APOE4) differs according to age in
Alzheimer's disease (AD) patients. We recruited 846 AD patients and 815 cognitively normal …

Neuroimaging studies of apolipoprotein E (ApoE4) have implicated its association with brain
atrophy in Alzheimer's disease. To date, few studies have used automated morphological …

The E4 allele of the ApoE gene has consistently been shown to be related to an increased
risk of Alzheimer's disease (AD). The E4 allele is also associated with functional and …

Background Alzheimer's disease (AD) is one of the forms of dementia, which affects> 25
million people around the world. AD is not restricted to developed or developing nations; …

The apolipoprotein E (APOE) gene has been consistently shown to modulate the risk of
Alzheimer's disease (AD). Here, using an AD and normal aging dataset primarily consisting …

Abstract Data on 2,045 non-demented individuals with memory complaints were drawn from
the Memento cohort study to examine the association between Apolipoprotein E ε4 allele …

Prior studies reported that the hippocampal volume is smaller in Alzheimer's disease
patients carrying the Apolipoprotein E ε4 allele (APOE4) versus patients who are non …

Apolipoprotein E4 (APOE4) is a genetic risk factor for developing Alzheimer's disease (AD).
Once AD manifests clinically, however, the effects of APOE4 are less clear. Therefore, we …

Background and purpose How the APOE genotype can differentially affect cortical and
subcortical memory structures in biomarker‐confirmed early‐onset (EOAD) and late‐onset …